• Kancera AB, of Stockholm, Sweden, said results of a collaboration with a research group at the Karolinska Institute showed that the survival of an aggressive type of human cancer cells from pancreatic cancer is ROR-1-dependent. Read More

LONDON – Adaptimmune Ltd. has published the first clinical data on its genetically modified T-cell technology, saying infusion of the engineered cells is safe, well tolerated and leads to a high response rate in a high-risk multiple myeloma population. Read More

Health spending across Europe fell in 2010 for the first time since 1975 as the economic crisis started to bite and governments started to cut back on expenditures, according to a newly published report on health care spending in Europe. Read More

Dutch start-up AIMM Therapeutics NV has inked a deal with a pharma partner, providing the means to ramp up development of its novel antibody platforms, and has attracted a leading immunologist and former head of the Novartis Institute for Biomedical Research, Jan de Vries, as CEO to spearhead that effort. Read More

LONDON – A compound isolated from a traditional Chinese medicine has specific anti-inflammatory properties and could offer a way to develop a new class of anti-inflammatory drugs. Read More

LONDON – There may not be that much competition, but AmpliPhi Biosciences Corp. now claims to be the world's leading bacteriophage company, following completion of its merger with Sydney, Australia-based Special Phage Services Pty. Read More